These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 32213513)

  • 1. Pathogenic Role of PPARα Downregulation in Corneal Nerve Degeneration and Impaired Corneal Sensitivity in Diabetes.
    Matlock HG; Qiu F; Malechka V; Zhou K; Cheng R; Benyajati S; Whelchel A; Karamichos D; Ma JX
    Diabetes; 2020 Jun; 69(6):1279-1291. PubMed ID: 32213513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topical and oral peroxisome proliferator-activated receptor-α agonist ameliorates diabetic corneal neuropathy.
    Mansoor H; Lee IXY; Lin MT; Ang HP; Xue YC; Krishaa L; Patil M; Koh SK; Tan HC; Zhou L; Liu YC
    Sci Rep; 2024 Jun; 14(1):13435. PubMed ID: 38862650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peroxisome proliferator-activated receptor-α (PPARα) regulates wound healing and mitochondrial metabolism in the cornea.
    Liang W; Huang L; Whelchel A; Yuan T; Ma X; Cheng R; Takahashi Y; Karamichos D; Ma JX
    Proc Natl Acad Sci U S A; 2023 Mar; 120(13):e2217576120. PubMed ID: 36943878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Protective Effect of PPARα in Endothelial Progenitor Cells Through Regulating Metabolism.
    Shao Y; Chen J; Dong LJ; He X; Cheng R; Zhou K; Liu J; Qiu F; Li XR; Ma JX
    Diabetes; 2019 Nov; 68(11):2131-2142. PubMed ID: 31451517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peroxisome proliferator-activated receptor α protects capillary pericytes in the retina.
    Ding L; Cheng R; Hu Y; Takahashi Y; Jenkins AJ; Keech AC; Humphries KM; Gu X; Elliott MH; Xia X; Ma JX
    Am J Pathol; 2014 Oct; 184(10):2709-20. PubMed ID: 25108226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sleep Deprivation Induces Dry Eye Through Inhibition of PPARα Expression in Corneal Epithelium.
    Tang L; Wang X; Wu J; Li SM; Zhang Z; Wu S; Su T; Lin Z; Chen X; Liao X; Bai T; Qiu Y; Reinach PS; Li W; Chen Y; Liu Z
    Invest Ophthalmol Vis Sci; 2018 Nov; 59(13):5494-5508. PubMed ID: 30658033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fenofibrate, a peroxisome proliferator-activated receptor alpha, improves myocardial capillary density in diabetic rats.
    Salehi E; Khazaei M
    J Pak Med Assoc; 2012 Mar; 62(3 Suppl 2):S9-12. PubMed ID: 22768449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accelerated diabetic nephropathy in mice lacking the peroxisome proliferator-activated receptor alpha.
    Park CW; Kim HW; Ko SH; Chung HW; Lim SW; Yang CW; Chang YS; Sugawara A; Guan Y; Breyer MD
    Diabetes; 2006 Apr; 55(4):885-93. PubMed ID: 16567507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of PPARα With the Canonic Wnt Pathway in the Regulation of Renal Fibrosis.
    Cheng R; Ding L; He X; Takahashi Y; Ma JX
    Diabetes; 2016 Dec; 65(12):3730-3743. PubMed ID: 27543085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PPARα Agonist Stimulated Angiogenesis by Improving Endothelial Precursor Cell Function Via a NLRP3 Inflammasome Pathway.
    Deng Y; Han X; Yao Z; Sun Y; Yu J; Cai J; Ren G; Jiang G; Han F
    Cell Physiol Biochem; 2017; 42(6):2255-2266. PubMed ID: 28817808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathogenic role of diabetes-induced PPAR-α down-regulation in microvascular dysfunction.
    Hu Y; Chen Y; Ding L; He X; Takahashi Y; Gao Y; Shen W; Cheng R; Chen Q; Qi X; Boulton ME; Ma JX
    Proc Natl Acad Sci U S A; 2013 Sep; 110(38):15401-6. PubMed ID: 24003152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peroxisome proliferator-activated receptor alpha-independent actions of fenofibrate exacerbates left ventricular dilation and fibrosis in chronic pressure overload.
    Duhaney TA; Cui L; Rude MK; Lebrasseur NK; Ngoy S; De Silva DS; Siwik DA; Liao R; Sam F
    Hypertension; 2007 May; 49(5):1084-94. PubMed ID: 17353509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of PPAR alpha by fenofibrate inhibits apoptosis in vascular adventitial fibroblasts partly through SIRT1-mediated deacetylation of FoxO1.
    Wang WR; Liu EQ; Zhang JY; Li YX; Yang XF; He YH; Zhang W; Jing T; Lin R
    Exp Cell Res; 2015 Oct; 338(1):54-63. PubMed ID: 26226216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peroxisome proliferator-activated receptor α (PPARα) contributes to control of melanogenesis in B16 F10 melanoma cells.
    Grabacka M; Wieczorek J; Michalczyk-Wetula D; Malinowski M; Wolan N; Wojcik K; Plonka PM
    Arch Dermatol Res; 2017 Apr; 309(3):141-157. PubMed ID: 28084540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PPARalpha agonist fenofibrate improves diabetic nephropathy in db/db mice.
    Park CW; Zhang Y; Zhang X; Wu J; Chen L; Cha DR; Su D; Hwang MT; Fan X; Davis L; Striker G; Zheng F; Breyer M; Guan Y
    Kidney Int; 2006 May; 69(9):1511-7. PubMed ID: 16672921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic effects of PPARα agonists on diabetic retinopathy in type 1 diabetes models.
    Chen Y; Hu Y; Lin M; Jenkins AJ; Keech AC; Mott R; Lyons TJ; Ma JX
    Diabetes; 2013 Jan; 62(1):261-72. PubMed ID: 23043158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral Peroxisome Proliferator-Activated Receptor-α Agonist Enhances Corneal Nerve Regeneration in Patients With Type 2 Diabetes.
    Teo CHY; Lin MT; Lee IXY; Koh SK; Zhou L; Goh DS; Choi H; Koh HWL; Lam AYR; Lim PS; Mehta JS; Kovalik JP; Coffman TM; Tan HC; Liu YC
    Diabetes; 2023 Jul; 72(7):932-946. PubMed ID: 36445944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic Effects of a Novel Agonist of Peroxisome Proliferator-Activated Receptor Alpha for the Treatment of Diabetic Retinopathy.
    Deng G; Moran EP; Cheng R; Matlock G; Zhou K; Moran D; Chen D; Yu Q; Ma JX
    Invest Ophthalmol Vis Sci; 2017 Oct; 58(12):5030-5042. PubMed ID: 28979999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelin-1-Induced Cell Hypertrophy in Cardiomyocytes is Improved by Fenofibrate: Possible Roles of Adiponectin.
    Jen HL; Yin WH; Chen JW; Lin SJ
    J Atheroscler Thromb; 2017 May; 24(5):508-517. PubMed ID: 27629528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The combined strategy with PPARα agonism and AT₁ receptor antagonism is not superior relative to their individual treatment approach in preventing the induction of nephropathy in the diabetic rat.
    Bishnoi HK; Mahadevan N; Balakumar P
    Pharmacol Res; 2012 Oct; 66(4):349-56. PubMed ID: 22796657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.